Evaluation of one-stage and chromogenic assays for the laboratory measurement of factor VIII activity following valoctocogene roxaparvovec infusion

被引：1
|
作者：
Platton, Sean [1 ]
Raheja, Priyanka [1 ]
Dale, Christopher [2 ,3 ]
Guy, Susan [4 ]
Yartey, Nada [2 ,3 ]
Bowyer, Annette [4 ]
机构：
[1] Barts Hlth NHS Trust, Royal London Hosp, Haemophilia Ctr, London, England
[2] Barts Hlth NHS Trust, Royal London Hosp, Haemostasis Lab, London, England
[3] Barts Hlth NHS Trust, Natl Hlth Serv East & South East London Pathol Par, London, England
[4] Sheffield Teaching Hosp NHS Fdn Trust, Royal Hallamshire Hosp, Dept Coagulat, London, England
来源：
HAEMOPHILIA | 2024年 / 30卷 / 05期
关键词：
GENE-THERAPY;
D O I：
10.1111/hae.15064
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1221 / 1224
页数：4
相关论文
共 50 条
  • [41] Effects of emicizumab on APTT, one-stage and chromogenic assays of factor VIII in artificially spiked plasma and in samples from haemophilia A patients with inhibitors
    Bowyer, Annette
    Kitchen, Steve
    Maclean, Rhona
    HAEMOPHILIA, 2020, 26 (03) : 536 - 542
  • [42] Method validation and clinical utility of chromogenic factor VIII assay compared to one-stage assay
    Wilmare Gouws
    Elsabie Botha
    Adele Visser
    Journal of Thrombosis and Thrombolysis, 2014, 37 : 210 - 215
  • [43] Discrepancy between one-stage and chromogenic factor VIII activity assay results can lead to misdiagnosis of haemophilia A phenotype
    Oldenburg, J.
    Pavlova, A.
    HAMOSTASEOLOGIE, 2010, 30 (04): : 207 - 211
  • [44] Discrepancy between the Results of One-Stage and Chromogenic Factor VIII Assays: Switch in Diagnosis from Mild to Moderate Hemophilia a in Three Cases
    Kizilocak, Hande
    Keegan, Jackie
    Young, Guy
    BLOOD, 2022, 140 : 11310 - 11311
  • [45] Single dose pharmacokinetic evaluation of ReFacto, the B domain-deleted recombinant factor VIII (BDDrFVIII), using one-stage and chromogenic assays: Comparison between plasma and concentrate laboratory standards.
    Morfini, M
    Cinotti, S
    Paladino, E
    Mannucci, PM
    Bellatreccia, A
    Bianchi, C
    BLOOD, 2000, 96 (11) : 490A - 490A
  • [46] Little discrepancy between one-stage and chromogenic factor VIII (FVIII)/IX assays in a large international cohort of persons with nonsevere hemophilia A and B
    Zwagemaker, Anne-Fleur
    Kloosterman, Fabienne R.
    Gouw, Samantha C.
    Boyce, Sara
    Brons, Paul
    Cnossen, Marjon H.
    Collins, Peter W.
    Eikenboom, Jeroen
    Hay, Charles
    Hengeveld, Rutger C. C.
    Jackson, Shannon
    Klopper-Tol, Caroline A. M.
    Kruip, Marieke J. H. A.
    Laros-van Gorkom, Britta
    Male, Christoph
    Nieuwenhuizen, Laurens
    Shapiro, Susan
    Fijnvandraat, Karin
    Copens, Michiel
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2023, 21 (04) : 850 - 861
  • [47] ONE-STAGE AND 2-STAGE FACTOR-VIII-ACTIVITY IN ACUTE LEUKAEMIA
    MESSARITAKIS, J
    PYROVOLAKIS, J
    DOURDOUREKAS, D
    GARDIKAS, C
    ACTA HAEMATOLOGICA, 1970, 44 (06) : 341 - +
  • [48] RELIABILITY OF STANDARD PLASMAS USED BY CLINICAL LABORATORIES FOR ONE-STAGE FACTOR-VIII ASSAYS
    HARPER, TA
    BAILEY, EL
    CHAUHAN, K
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1981, 75 (02) : 197 - 200
  • [49] A COLLABORATIVE STUDY ON THE SUITABILITY OF COMMERCIAL, ASSAYED PLASMAS FOR ONE-STAGE FACTOR-VIII ASSAYS
    HARPER, TA
    CHAUHAN, K
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1982, 77 (05) : 614 - 618
  • [50] Stability of dilutions of the recombinant factor VIII Kogenate FS determined by one-stage and chromogenic assays using plasma-derived and concentrate standards.
    Rand, ML
    Schmugge, M
    Clark, D
    Lillicrap, D
    Blanchette, VS
    BLOOD, 2002, 100 (11) : 711A - 711A
12345